Skip to content
Screener

Arbutus Biopharma Corporation ABUS Income Statement

Q2 '26Q1 '26Q4 '25Q3 '25Q2 '25
Total revenue
$1.01M-90.6%$179.13M+10,055%$1.05M-33.2%$529K-60.5%$10.74M+522%
Research and development
$2.9M-47.3%$4.12M-54.0%$5.01M-43.2%$5.78M-59.5%$5.5M-64.6%
General and administrative
$3.87M+16.2%$5.89M+1.0%$3.69M-21.7%$3.04M-32.9%$3.33M-55.9%
Total operating expenses
$6.98M-24.6%$10.22M-62.8%$6.34M-59.1%$9.19M-59.7%$9.25M-60.3%
Operating income
-$5.96M-501%$168.91M+757%-$5.29M+62.0%-$8.66M+59.6%$1.49M+107%
Operating margin
-588.2%-602pp94.3%+1,551pp-503.3%+382pp-1,636.9%-35.7pp13.9%+1,264pp
Interest expense
$18K-35.7%$17K-39.3%$18K-40.0%$23K-20.7%$28K-17.6%
Other income (expense), net
$821K-20.7%$787K-32.9%$1.53M+9.5%$917K-46.8%$1.04M-42.1%
Net income
-$5.14M-304%$169.7M+792%-$3.76M+70.0%-$7.74M+60.7%$2.52M+113%
Net margin
-507.2%-531pp94.7%+1,485pp-357.4%+439pp-1,463.5%+9.0pp23.5%+1,170pp
Diluted earnings per share
-$0.03-400%$0.87+769%-$0.01+85.7%-$0.04+60.0%$0.01+109%
EBITDA
-$5.95M-497%$168.92M+766%-$5.2M+61.7%-$8.65M+59.0%$1.5M+107%
EBITDA margin
-587.1%-601pp94.3%+1,532pp-494.7%+369pp-1,634.8%-58.7pp14%+1,244pp
EBIT
-$5.96M-501%$168.91M+757%-$5.29M+62.0%-$8.66M+59.6%$1.49M+107%

FAQ

What is Arbutus Biopharma Corporation's revenue?
Arbutus Biopharma Corporation (ABUS) generated $181.7M in revenue over the trailing twelve months, up 1078.8% year over year.
Is Arbutus Biopharma Corporation profitable?
Arbutus Biopharma Corporation reported $153.1M in net income over the trailing twelve months, a 84.2% net margin.
What is Arbutus Biopharma Corporation's earnings per share?
Arbutus Biopharma Corporation's diluted EPS over the trailing twelve months is $0.79.
Where does Arbutus Biopharma Corporation's income statement data come from?
Every line is extracted from Arbutus Biopharma Corporation's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.